A discussion of the 2026–2030 development strategy was held in the conference hall of the joint-stock company "Dori-Darmon".

The strategy was developed by a team led by Chief Financial Officer I. Razakov and addresses key priorities such as strengthening the company’s position in Uzbekistan’s pharmaceutical market, increasing market share, growing annual sales volumes, expanding wholesale and retail operations, and further developing partnerships with both domestic and international manufacturers.

Particular attention in the strategy is given to cost optimization, the opening of new pharmacies, improving the quality of customer service through the implementation of modern information and communication technologies and artificial intelligence systems, as well as enhancing staff qualifications.

Following active discussions, it was decided to revise the five-year development strategy taking into account the proposals received.